Research Poster: Hoxb8-derived anti-GPC3 CAR expressing macrophages as a preclinical model for HCC immunotherapies
My research project involved engineering macrophages from Hoxb8 progenitors to express a GPC3-specific CAR for targeting hepatocellular carcinoma. The cells retained macrophage identity and CAR expression, offering a scalable platform to develop macrophage-based immunotherapies for HCC.

Recommended Content
Arts & Humanities, Medicine & Health, Social Sciences, STEM, Leadership, Women in Business, Research, Durham University, Trinity College Dublin, University College London, University of Leeds, University of St Andrews, University of York, London Business School, Leadership & Research Laidlaw Scholars, Alumni, Learning Hub, Opportunities, Saïd Business School, University of Cambridge, London School of Economics and Political Science, Women in Business, Imperial College London, University of Oxford - SDG Impact Lab
Please sign in
If you are a registered user on Laidlaw Scholars Network, please sign in